SAN FRANCISCO — Can artificial intelligence help battle malaria and other infectious diseases? Intellectual Ventures CEO Nathan Myhrvold says it’s time… Read More
Juno Therapeutics, the Seattle-based biotech company developing immunotherapy cancer treatments, unveiled promising new data from a study on its flagship… Read More
The U.S. healthcare system faces a myriad of challenges today, including uncertainty over federal regulation and shifting payer systems. You… Read More
Seattle Genetics, the maker of cancer drug Adcetris, beat analyst expectations by a noticeable margin in its third-quarter earnings, reported… Read More
Virginia-based telemedicine provider Avizia announced Tuesday that it has acquired Carena, a Seattle-based telemedicine startup that builds the technology behind virtual doctor’s… Read More
EchoNous — a company based in Redmond, Wash., working to develop next-generation ultrasound devices — announced Thursday that it has received… Read More
The Seattle Children’s Research Institute announced Wednesday that it has licensed a new gene therapy technology to Cambridge, Mass.,-based biotech company… Read More
Revalesio, a biomedical company headquartered in Tacoma, Wash., says it’s been cleared to benefit from federal incentives for the development… Read More